# MetaNovas

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/metanovas

- Industry: Pharmaceuticals
- Headquarters: Shanghai, China
- Website: www.metanovas.com
- Total disclosed funding: $10M
- Latest round: Series A (Mar 9, 2026)
- Investors on record: 9

## About

Based in Shanghai, China, and established in 2021, Shanghai Yuanxin Zhiyao Technology Co., Ltd., dba MetaNovas, is a drug developer that mainly provides anti-ageing and metabolic drugs. It has an office in Silicon Valley, USA. The team members are from MIT, Stanford, Google, Facebook, and Kite Pharma. The company cooperates with Shenzhen Huada Gene Technology Co., Ltd., L'Oréal, and Beiersdorf AG. In March 2026, MetaNovas closed Series A+ funding from Fuhua Capital, Hillhouse Investment, and Kangaroo Capital.

The company is developing anti-ageing drugs, metabolic drugs, and preventing neurodegenerative diseases based on deep learning, knowledge graph, and multi-omics analysis. It developed multiple platforms, including the Mete-KG knowledge graph platform, Meta-Omics analysis and computing platform, and Meta-NLP clinical and literature data mining platform. The drugs developed include anti-inflammatory peptides, anti-acne peptides, anti-wrinkle peptides, gum protection peptides, and vaginal care antimicrobial peptides.

The company generates revenue by providing anti-ageing and metabolic drugs based on its technology platform. The company will use the March 2026 funding to further advance its intelligent agent-driven research and development system to support a growing portfolio of new material pipelines and commercialization partnerships.

## Funding rounds

- Series A, Mar 9, 2026 — Hillhouse Investment, Fuhua Capital, Kangaroo Capital
- Series A, Dec 2, 2024 — GL Ventures, Guangzhou Ruoyuchen Technology Co., Ltd., Baoding Venture Capital
- Angel, Mar 31, 2022, $10M — Shanghai Jianyi Private Equity Fund Management, Redhill Capital, Neux Capital
- Series A, date not disclosed — Hillhouse Investment, Fuhua Capital, Kangaroo Capital

## Investors

- Hillhouse Investment (https://capitalatlas.ai/funds/hillhouse-investment) — Series A
- Fuhua Capital — Series A
- Kangaroo Capital (https://capitalatlas.ai/funds/kangaroo-capital) — Series A
- Shanghai Jianyi Private Equity Fund Management (https://capitalatlas.ai/funds/shanghai-jianyi-private-equity-fund-management) — Angel
- Redhill Capital (https://capitalatlas.ai/funds/redhill-capital) — Angel
- Neux Capital — Angel
- GL Ventures (https://capitalatlas.ai/funds/gl-ventures) — Series A
- Guangzhou Ruoyuchen Technology Co., Ltd. — Series A
- Baoding Venture Capital — Series A